H.R. 124 · 118th Congress · House

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Active· Referred to the Subcommittee on Health.
Introduced
Jan 9, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Action Timeline

4
  1. JAN 20, 2023Committee

    Referred to the Subcommittee on Health.

  2. JAN 09, 2023IntroReferral

    Introduced in House

  3. JAN 09, 2023IntroReferral

    Introduced in House

  4. JAN 09, 2023IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Jan 20, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Jan 9, 2023

Active